Literature DB >> 21415124

Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients.

Vera M C Salemi1, Carlos E Rochitte, Afonso A Shiozaki, Joalbo M Andrade, José R Parga, Luiz F de Ávila, Luiz A Benvenuti, Ismar N Cestari, Michael H Picard, Raymond J Kim, Charles Mady.   

Abstract

BACKGROUND: Endocardial fibrous tissue (FT) deposition is a hallmark of endomyocardial fibrosis (EMF). Echocardiography is a first-line and the standard technique for the diagnosis of this disease. Although late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) allows FT characterization, its role in the diagnosis and prognosis of EMF has not been investigated. METHODS AND
RESULTS: Thirty-six patients (29 women; age, 54±12 years) with EMF diagnosis after clinical evaluation and comprehensive 2-dimensional Doppler echocardiography underwent cine-CMR for assessing ventricular volumes, ejection fraction and mass, and LGE-CMR for FT characterization and quantification. Indexed FT volume (FT/body surface area) was calculated after planimetry of the 8 to 12 slices obtained in the short-axis view at end-diastole (mL/m(2)). Surgical resection of FT was performed in 16 patients. In all patients, areas of LGE were confined to the endocardium, frequently as a continuous streak from the inflow tract extending to the apex, where it was usually most prominent. There was a relation between increased FT/body surface area and worse New York Heart Association functional class and with increased probability of surgery (P<0.05). The histopathologic examination of resected FT showed typical features of EMF with extensive endocardial fibrous thickening, proliferation of small vessels, and scarce inflammatory infiltrate. In multivariate analysis, the patients with FT/body surface area >19 mL/m(2) had an increased mortality rate, with a relative risk of 10.8.
CONCLUSIONS: Our study provides evidence that LGE-CMR is useful in the diagnosis and prognosis of EMF through quantification of the typical pattern of FT deposition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415124     DOI: 10.1161/CIRCIMAGING.110.950675

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  26 in total

1.  Endomyocardial fibrosis: missing tricuspid valve and Fontan-like circulation.

Authors:  Yasuyuki Shiraishi; Takashi Kohno; Yoko Fujii-Nishimura; Masayuki Shimoda; Yoshihiko Ikeda; Kazuaki Nakajima; Takahiko Nishiyama; Nobuhiro Nishiyama; Mitsushige Murata; Yuichiro Maekawa; Motoaki Sano; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2016-01-08       Impact factor: 2.037

Review 2.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

3.  [Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging].

Authors:  E Di Cesare; F Cademartiri; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; A Romagnoli; V Russo; F Sardanelli; L Natale; J Bogaert; A De Roos
Journal:  Radiol Med       Date:  2012-11-26       Impact factor: 3.469

Review 4.  Cardiac MRI: a central prognostic tool in myocardial fibrosis.

Authors:  Bharath Ambale-Venkatesh; João A C Lima
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

Review 5.  Left atrium: the last bulwark before overt heart failure.

Authors:  Matteo Cameli; Giulia Elena Mandoli; Sergio Mondillo
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

6.  Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.

Authors:  Dongting Liu; Xiaohai Ma; Jiayi Liu; Lei Zhao; Hui Chen; Lei Xu; Zhonghua Sun; Zhanming Fan
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-13       Impact factor: 2.357

7.  Complex right atrial mass in endomyocardial fibrosis: a diagnostic dilemma.

Authors:  Arun Sharma; Niraj Nirmal Pandey; Amarinder Singh Malhi; Sanjeev Kumar
Journal:  BMJ Case Rep       Date:  2019-01-04

8.  Right ventricular endomyocardial fibrosis - A case report.

Authors:  Deepak Madi; Basavaprabhu Achappa; Narasimha Pai; Padmanabha Kamath
Journal:  Australas Med J       Date:  2013-02-28

9.  Obstructive left heart disease in neonates with a "borderline" left ventricle: diagnostic challenges to choosing the best outcome.

Authors:  Giulia Tuo; Sachin Khambadkone; Oliver Tann; Martin Kostolny; Graham Derrick; Victor Tsang; Ian Sullivan; Jan Marek
Journal:  Pediatr Cardiol       Date:  2013-03-12       Impact factor: 1.655

10.  Endomyocardial fibrosis causing stroke in a young man.

Authors:  Ali Raza Rajani; Kosar Hussain; Fahad Omar Baslaib; Sumbul Javed Mirza
Journal:  BMJ Case Rep       Date:  2012-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.